Expanding the Evidence Base to Inform Vaccine Introduction: Program Costing and Cost-effectiveness Analyses


The studies published in this supplement feature work conducted by prominent researchers and investigators in the field of vaccine economics, PAHO/WHO Member States, other WHO Member States outside of PAHO that received training from the PAHO ProVac Initiative and other partners that comprise the EPIC (EPI Costing and Financing of Routine Immunization and New Vaccines) group. All this work was made possible by financial support from the Bill and Melinda Gates Foundation. The views expressed herein are those of the authors and do not necessarily reflect the official policy or position of the Bill and Melinda Gates Foundation or the Pan American Health Organization.

Edited by J.K. Andrus, D.G. Walker
Volume 33, Supplement 1,
Pages A1-A254 (7 May 2015)